DAX 25.818 +0,1%ESt50 6.398 -0,2%MSCI World 4.865 +0,5%Top 10 Crypto 8,41 +2,0%Nas 26.121 +1,1%Bitcoin 55.210 -1,3%Euro 1,1437 -0,1%Öl 72,5 +0,7%Gold 4.131 -0,8%
Beliebte Suche
DAX 40ÖlpreisEuro - DollarBitcoin - EuroGoldpreis
Meistgesucht
BioNTech (ADRs)A2PSR2TeslaA1CX3TAmazon906866NEL ASAA0B733Microsoft870747Apple865985Siemens EnergyENER6YBASFBASF11NVIDIA918422Lufthansa823212Mercedes-Benz Group (ex Daimler)710000BayerBAY001Daimler TruckDTR0CKPlug PowerA1JA81TUITUAG00
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero.Hier informieren
Top News
Suche...
Jetzt kostenlos
bei finanzen.net anmelden
Watchlists & MusterdepotsTools & integriertes TradingNewsletter, Trading-Desk uvm.
Schon einen Account? Anmelden

EQS-NVR: Dermapharm Holding SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Werte in diesem Artikel
Aktien
Dermapharm Holding SE
46.90 EUR 0.00 EUR 0.0 %
Charts | News | Analysen
Aktie kaufen

EQS Total Voting Rights Announcement: Dermapharm Holding SE / Total Voting Rights Announcement
Dermapharm Holding SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

20.04.2026 / 11:50 CET/CEST
Total Voting Rights Announcement transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Werbung

Publication of new total number of voting rights according to Sec. 41 WpHG

1. Details of issuer
Dermapharm Holding SE
Lil-Dagover-Ring 7
82031 Grünwald
Germany

2. Type of capital measure or other measure
  Type of capital measure or other measure Date of status / date of effect
  Conditional capital increase (Sec. 41 para. 2 WpHG)
X Other (capital) measure (Sec. 41 para. 1 WpHG) 16 Apr 2026

3. New total number of voting rights:
49.540.810
number of multiple voting rights thereof: 0


20.04.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News

Language: English
Company: Dermapharm Holding SE
Lil-Dagover-Ring 7
82031 Grünwald
Germany
Internet: ir.dermapharm.de

 
End of News EQS News Service
Werbung

2308244  20.04.2026 CET/CEST

Aktuelle Dermapharm Aktie News

Werbung

Dermapharm Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Dermapharm nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
27.05.26 Dermapharm Hold Jefferies & Company Inc.
14.05.26 Dermapharm Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
31.03.26 Dermapharm Hold Jefferies & Company Inc.
10.03.26 Dermapharm Hold Jefferies & Company Inc.
10.03.26 Dermapharm Hold Jefferies & Company Inc.